Pfizer Stock Price and Value Analysis

Should you buy Pfizer stock? (NYSE:PFE). Let's see how it does in our automated value investing analysis system.

  • This company has a large dividend yield!
  • This company is a well-established bedrock.
  • This company is making money at a modest rate.
  • This stock looks overpriced.
  • This company has wild ups and downs.

Inside the PFE Numbers

PFE Price
(Pfizer stock price per share)
[?] PFE Fair Price
(based on intrinsic value)
[?] PFE Safety Price (based on a variable margin of safety) $26.45
[?] PE Ratio versus Sector 55% higher than other Healthcare stocks
[?] PE Ratio versus Industry 30% lower than other Unknown stocks
[?] Cash Yield 6.04%
[?] Free Cash Flow Jitter 43%
[?] Dividend Yield 4%
Shares Shorted 62,511,349

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 62,511,349 shares shorted. With 5,607,637,433 shares available for purchase and an average trading volume over the past 10 trading days of 22,644,380, it would take at least 2.761 days for all of the short holders to cover their shorts.

Is Pfizer Stock on Sale?

We believe that Pfizer may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Pfizer looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy PFE Stock?

Does Pfizer have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.